Use of cyclosporine in hematopoietic cell transplantation

W. J. Hogan, R. Storb

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Early attempts to perform successful allogeneic hematopoietic stem cell transplants were plagued by graft rejection and graft-versus-host disease, leading many investigators to lose hope that bone marrow transplantation could ever become a useful therapeutic approach in clinical medicine. Although many subsequent discoveries contributed to the successful transformation of this area of research into lifesaving therapy, there can be no doubt that the discovery of cyclosporine (CsA) constituted one of the major advances. Even today, more than 25 years after the first description of its use in humans, CsA remains one of the cornerstones of therapy for the majority of patients undergoing allogeneic hematopoietic cell transplantation (HCT). In this review we will recount the events that have established CsA as a foundation of HCT.

Original languageEnglish (US)
Pages (from-to)S367-S371
JournalTransplantation proceedings
Issue number2 SUPPL.
StatePublished - Mar 2004

ASJC Scopus subject areas

  • Surgery
  • Transplantation


Dive into the research topics of 'Use of cyclosporine in hematopoietic cell transplantation'. Together they form a unique fingerprint.

Cite this